sesone has been researched along with ma-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryce, RA; Douglas, KT; Freeman, S; Gbaj, A; Jaffar, M; McNally, VA; Stratford, IJ | 1 |
| Basso, LA; Bergo, P; Campos, MM; da Silva Dadda, A; de Moura Sperotto, ND; Deves Roth, C; Duarte de Souza, AP; Ev Neves, C; Freitas de Freitas, T; Machado, P; Moura, S; Reisdorfer Paula, F; Rodrigues-Junior, VS; Santos, DS; Souza Macchi, F; Valim Bizarro, C | 1 |
2 other study(ies) available for sesone and ma-1
| Article | Year |
|---|---|
Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening.
Topics: Binding Sites; Computer Simulation; Crystallography, X-Ray; Databases, Genetic; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Hydrazines; Imidazoles; Kinetics; Models, Molecular; Recombinant Proteins; Structure-Activity Relationship; Thymidine; Thymidine Phosphorylase | 2003 |
Design of Novel Inhibitors of Human Thymidine Phosphorylase: Synthesis, Enzyme Inhibition, in Vitro Toxicity, and Impact on Human Glioblastoma Cancer.
Topics: Animals; Area Under Curve; Brain Neoplasms; Cell Line; Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Glioblastoma; Half-Life; Humans; Thymidine Phosphorylase | 2019 |